Alexander Crichton

We are so thrilled to have matched Aaron and Mohammed to our program @DeBakeyCVedu! Welcome to the family. @AlanLumsdenMD @BavareMd @SandraV19359714 @MadelineDrakeMD

Huge congrats to Eniko Pomozi for winning First Prize #AVF2026 @VenousForum! Proud of our lab @HMethodistCV where we combine MRI, histo, human thrombus to understand clot biology and treatment. Amazing work by Eniko + team. Check us out at European Venous Forum in June!

should be illegal for managers to sub defenders on 59min currently holding a clean sheet ie preventing the 2 points for 60min plus the clean sheet points @ManCity 🤣 Don't they know the world revolves around my @OfficialFPL score @BBCSport says subbed at 60min #gimmedapoints 🤣

Thanks for highlighting our paper! #CLIFighters Join the discussion!

Congratulations to our post doc Eniko! Highlighted in the #VEITH bulletin. Pushing PAD beyond anatomy toward biology-guided diagnosis is exactly the paradigm shift the field needs. HiPath is a powerful vision for what’s next. @AlanLumsden @HMethodistCV @DeBakeyCVedu

Big day at HMH PVD Device Core with the TCAT team (MicroVention/@Terumo), we tested next-gen BTK devices on real CLTI pathology: donated limbs, phenotyped with MRI + OCT. The future is informed design: the right device, right patient, first time, every time. @AlanLumsdenMD

Couldn't be more proud to be part of this center lead by the visionary @AlanLumsdenMD

Huge congratulations to @SandraV19359714 Sandra Vale from Houston Methodist Hospital - now the President-Elect of the APAVS! @AlanLumsdenMD @CBavare

🌍 🎯 QUERY: What is the True Foundation of Vascular Progress? 💥 Celebrating our Rising Impact Factor, our 2025 Reviewers, and the Future of #EJVESForum Happy New Year! As we begin 2026, we pause to reflect on a landmark year. Science is more than just data; it is a community—a family—built on the dedication of those who came before us and the tireless work of those currently behind the scenes. 💡 2025: A YEAR OF SERVICE & GROWTH Inspired by the collaborative spirit of the global vascular community, we want to celebrate the pillars of our journal: · Rising Impact: Since receiving our first Impact Factor in 2023, we have seen remarkable growth, with our Impact Factor rising to 1.8 in 2025! This climb reflects the increasing relevance of the clinical insights shared by our authors. · Reviewers & Commentaries: Success would be impossible without our reviewers. Beyond ensuring quality, your Reviewer Commentaries are essential to the journal's mission, providing the context and "expert take" that deepen the community's understanding of every paper. · The Authors: Thank you for your trust in sharing your research and clinical "lessons learned" with us throughout 2025. · The Editorial Team: Recognition to our associate editors and production staff, whose meticulous work ensures the highest standards in every publication. 🚀 2026: INNOVATION & FUTURE PERSPECTIVES This year, we are taking important steps to bring high-quality science to an even broader audience: · Digital Transformation: We are enhancing our integration of videos and multimedia to enrich clinical discussion and bring surgical techniques to life. · Expanding Global Reach: With our rising IF, we are focused on even broader indexing to ensure your work has the visibility it deserves. · Reviewer Mentorship: Launching initiatives to support the next generation of experts in developing their peer-review and commentary skills. 👉 TAKEAWAY: A Legacy in Every Review Every contribution strengthens the advancement of vascular surgery. We honour the legacy of the greats who inspired us by carrying forward their commitment to ethical standards and collaborative spirit into this new year. Thank you for being an essential part of our journey. Let's make 2026 our best year yet! #EJVESforum #ImpactFactor #VascularSurgery #PeerReview #AcademicPublishing #MedEd #ESVScommunity #VasculaRes #SurgicalEducation #ScientificIntegrity #NewYear2026 @vascularis @bazinger_z @FLareyre @maria_katsarou_ @NicLeoneMD @ESVSmembership @EVST_ESVS

Honored to present @ParisVascular! AI hasn’t failed PAD, PAD imaging has failed AI. Angios can be deceiving. QISS MRI more sensitive for runoff and UTE MRI predicts endo failure. Feed AI real imaging/biology, not bad surrogates, and it can finally help us save limbs.

@AlanLumsdenMD your team had party last night. Seems you weren’t invited. We took this photo and the whole room agreed we’re officially the better-looking vascular squad. If this causes a sudden urge in Houston to start doing endovascular CFA repairs, now you know why.

@MadelineDrakeMD @MAPopplewell @GarnhamAndy ROY LAB ROY LAB @trisharoymd

@VascularABC @MAPopplewell @GarnhamAndy You’re a star!

Had a great time presenting our work on UTE MRI and CLTI plaque morphology at #VSASM2025. Honoured to win British Journal of Surgery 1st place oral presentation prize! Great to see many familiar faces @MAPopplewell @GarnhamAndy too!

Congratulations to @VascularABC for first prize at #VSASM2025! MRI redefines how we see and manage PAD. It is so exciting to see that message resonate with vascular societies across the globe! @AlanLumsdenMD

Huge congratulations to @MadelineDrakeMD for her outstanding presentation at #VEITH25. It's official, we need to get QISS MRA into the guidelines for renal patients! @AlanLumsdenMD @jmills1955

MAC is untreatable - can’t sew to it, can’t dilate it and we see it too late. MRI can see early modifiable MAC. Spatial transcriptomics can reveal what drives it. We stabilized atherosclerotic plaques with statins. Now it’s time to do the same for MAC. #VEITH25 @AlanLumsdenMD

It was great to present our work on immediate technical failure for the first time at #VEITH2025. @trisharoymd @AlanLumsdenMD @HMethodistCV

@trisharoymd presenting at #veith2025 on how medial artery calcification is not inert and is something we can target using radio genomics @AlanLumsdenMD @HMethodistCV

As I have stated - this lab will "change" our concepts and approach to PVD - thee best human limb model to test devices- will not and should not come to market without going their rigorous evaluation. The doors are open! @trisharoymd @VascularABC @mmonterobaker @farkomd vascularspecialistonline.com/non-contrast-m…

Great to have @MAPopplewell present in person @HMethodistCV. Talking BASIL trials and platform study for groin and amputation wound infections